PhaseRx, Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2016. For the quarter, the company reported loss from operations of $9,811,000 against $1,443,000 for the same period a year ago. Net loss was $11,084,000 or $1.84 per basic and diluted share against $1,747,000 or $3.29 per basic and diluted share for the same period a year ago. For the six months, the company reported loss from operations of $11,924,000 against $2,634,000 for the same period a year ago. Net loss was $13,317,000 or $4.05 per basic and diluted share against $3,167,000 or $6.27 per basic and diluted share for the same period a year ago.